Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice
- PMID: 2786994
- DOI: 10.1038/340061a0
Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice
Abstract
Infection of mice with Moloney murine leukaemia virus (MuLV) induces T-cell lymphomas after an average latency period of 150 days. In these lymphomas the MuLV DNA is frequently integrated into the mouse chromosomal DNA in the vicinity of the pim-1 oncogene. Transgenic mice overexpressing the pim-1 oncogene are predisposed to develop T-cell lymphomas, but only to the extent that approximately 10% of the mice develop a lymphoma within 240 days. When these mice are infected with MuLV, lymphomas develop in all mice in only 50-60 days. In these lymphomas MuLV DNA is integrated near either the c-myc or N-myc gene, suggesting that pim-1 and myc synergize in lymphomagenesis. To determine whether this system has a more general application, we have now tested the susceptibility of pim-1 transgenic mice to N-ethyl-N-nitrosourea (ENU), a chemical carcinogen. With a single low dose of ENU, nearly all pim-1 transgenic mice, but only 15% of non-transgenic mice, develop T-cell lymphomas within 200 days. All ENU-induced lymphomas in both pim-1 transgenic and non-transgenic mice express high levels of c-myc messenger RNA, supporting the notion that pim-1 and c-myc synergize in lymphoma induction. We propose that pim-1 transgenic mice could be used to test the oncogenic potential of other chemical compounds.
Similar articles
-
Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.Cancer Res. 1991 Feb 1;51(3):958-63. Cancer Res. 1991. PMID: 1988138
-
Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.Oncogene. 1995 Nov 2;11(9):1729-36. Oncogene. 1995. PMID: 7478600
-
E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.Oncogene. 1991 Nov;6(11):1941-8. Oncogene. 1991. PMID: 1658705
-
Transgenic mice as a means to study synergism between oncogenes.Int J Cancer Suppl. 1989;4:22-5. doi: 10.1002/ijc.2910440706. Int J Cancer Suppl. 1989. PMID: 2681009 Review.
-
Tumorigenesis in transgenic mice: identification and characterization of synergizing oncogenes.J Cell Biochem. 1991 Oct;47(2):130-5. doi: 10.1002/jcb.240470206. J Cell Biochem. 1991. PMID: 1661736 Review.
Cited by
-
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.Blood. 2006 Oct 1;108(7):2407-15. doi: 10.1182/blood-2006-04-020305. Epub 2006 Jun 8. Blood. 2006. PMID: 16763206 Free PMC article.
-
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.EMBO J. 2005 Jan 26;24(2):368-81. doi: 10.1038/sj.emboj.7600521. Epub 2005 Jan 6. EMBO J. 2005. PMID: 15635450 Free PMC article.
-
High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model.Cancer Sci. 2005 Jun;96(6):309-16. doi: 10.1111/j.1349-7006.2005.00056.x. Cancer Sci. 2005. PMID: 15958052 Free PMC article.
-
Targeting Pim kinases in hematological cancers: molecular and clinical review.Mol Cancer. 2023 Jan 25;22(1):18. doi: 10.1186/s12943-023-01721-1. Mol Cancer. 2023. PMID: 36694243 Free PMC article. Review.
-
In vivo analysis of Pim-1 deficiency.Nucleic Acids Res. 1993 Oct 11;21(20):4750-5. doi: 10.1093/nar/21.20.4750. Nucleic Acids Res. 1993. PMID: 8233823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases